838 related articles for article (PubMed ID: 27167529)
1. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
[TBL] [Abstract][Full Text] [Related]
2. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
3. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
4. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
[TBL] [Abstract][Full Text] [Related]
7. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
Maleki A; Hamidi M
Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
[TBL] [Abstract][Full Text] [Related]
8. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
[TBL] [Abstract][Full Text] [Related]
10. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
[TBL] [Abstract][Full Text] [Related]
11. Improving bioavailability of silybin by inclusion into SBA-15 mesoporous silica materials.
Fu T; Lu J; Guo L; Zhang L; Cai X; Zhu H
J Nanosci Nanotechnol; 2012 May; 12(5):3997-4006. PubMed ID: 22852339
[TBL] [Abstract][Full Text] [Related]
12. Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design:
Musallam AA; Mahdy MA; Elnahas HM; Aldeeb RA
Drug Deliv; 2022 Dec; 29(1):1582-1594. PubMed ID: 35612286
[TBL] [Abstract][Full Text] [Related]
13. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
[TBL] [Abstract][Full Text] [Related]
14. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
15. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
[TBL] [Abstract][Full Text] [Related]
16. Improved solubility of lornoxicam by inclusion into SBA-15: Comparison of loading methods.
Dadej A; Woźniak-Braszak A; Bilski P; Piotrowska-Kempisty H; Józkowiak M; Pawełczyk A; Dadej D; Łażewska D; Jelińska A
Eur J Pharm Sci; 2022 Apr; 171():106133. PubMed ID: 35066153
[TBL] [Abstract][Full Text] [Related]
17. Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica.
Wang Z; Chen B; Quan G; Li F; Wu Q; Dian L; Dong Y; Li G; Wu C
Int J Nanomedicine; 2012; 7():5807-18. PubMed ID: 23209366
[TBL] [Abstract][Full Text] [Related]
18. Preparation of a novel starch-derived three-dimensional ordered macroporous carbon for improving the dissolution rate and oral bioavailability of water-insoluble drugs.
Liu Y; Wu C; Hao Y; Xu J; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P
J Pharm Biomed Anal; 2016 Jan; 118():267-275. PubMed ID: 26580824
[TBL] [Abstract][Full Text] [Related]
19. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
Biswas N
Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]